<img height="1" width="1" src="https://www.facebook.com/tr?id=2789950834666001&amp;ev=PageView&amp;noscript=1">
A 7 minute read
breast-cancer-ribbon
April 15, 2020

Incidence rates of breast cancer are steadily increasing in the U.S. With an estimated 276,480 new invasive breast cancer diagnoses projected among U.S. women by the end of 2020, the time for innovative therapeutics and treatments is now.

Todd Bellemare, VP of Professional Services here at Definitive Healthcare, recently hosted a webinar on oncology market trends and opportunities. In case you weren’t able to attend, here’s a glimpse of what you missed.

Which U.S. regions have the highest breast cancer rates?

Fig. 1 Heatmap created with the Definitive Healthcare PatientFinder platform. Data sourced from calendar year 2019 (most recent available). Data accessed March 2020.

With the figure above, Bellemare highlighted areas in the U.S. with the highest densities of breast cancer patients seeking treatment between 2016 and 2019. In general, the eastern half of the U.S. — especially the northeastern region — has a much higher patient diagnosis volume than the western half. California maintains the highest breast cancer patient diagnosis volume for western U.S.

Which hospitals had the most breast cancer diagnoses in 2019?

Rank

Hospital

State

Definitive ID

ICD-10 Code

ICD-10 Description

Total  Claims

1

ArchCare at Calvary Hospital - Bronx Campus

NY

5636

C50919

Malignant neoplasm of unspecified site of unspecified female breast

101

2

ArchCare at Calvary Hospital - Bronx Campus

NY

5636

C50912

Malignant neoplasm of unspecified site of left female breast

82

3

Long Island Jewish Medical Center

NY

2828

C50911

Malignant neoplasm of unspecified site of right female breast

55

4

Long Island Jewish Medical Center

NY

2828

C50912

Malignant neoplasm of unspecified site of left female breast

55

5

NewYork-Presbyterian/Weill Cornell Medical Center

NY

541974

C50912

Malignant neoplasm of unspecified site of left female breast

53

6

NewYork-Presbyterian/Weill Cornell Medical Center

NY

541974

C50911

Malignant neoplasm of unspecified site of right female breast

49

7

Auxilio Mutuo Hospital

PR

4674

C50912

Malignant neoplasm of unspecified site of left female breast

48

8

Auxilio Mutuo Hospital

PR

4674

C50412

Malignant neoplasm of upper-outer quadrant of left female breast

48

9

Bayamon Medical Center

PR

4634

C50412

Malignant neoplasm of upper-outer quadrant of left female breast

48

10

ArchCare at Calvary Hospital - Bronx Campus

NY

5636

C50911

Malignant neoplasm of unspecified site of right female breast

47

Fig. 2 Data from Definitive Healthcare's Hospitals & IDNs database. Claims data is sourced from the Centers for Medicare and Medicaid Services (CMS) Medicare Standard Analytical Files (SAF), calendar year 2019 (most recent available). Data accessed March 2020. 

Of the top 10 hospitals with the highest number of breast cancer related diagnoses in 2019, New York hospitals ranked seven times — confirming that the Northeastern portion of the U.S. should be a top priority for those looking to bring new breast cancer therapies into market. Interested organizations, like those in pharma or the other life sciences, can start with hospitals like those ranked in this list and track referral patterns for a more complete picture of the patient journey.

Tracking breast cancer patients in southern California

As seen in the above heatmap, there are dense clusters of patient activity all throughout the U.S. Steering away from the more obvious choices, Bellemare chose to provide a deeper analysis of the southern California market, identifying which hospitals in the region are most accustomed to breast cancer patient diagnoses and treatments.

Southern California hospitals ranked by breast cancer market share

 

 

 

 

Figs. 3 & 4 Created using the Definitive Healthcare PatientFinder platform and Hospitals & IDNs database. Data sourced from calendar year 2019 (most recent available). Data accessed March 2020.

Highlighted hospitals include Hoag Hospital Newport Beach, Torrance Memorial Medical Center, Cedars-Sinai Medical Center, and City of Hope Helford Clinical Research Hospital, which collectively own almost 25 percent of the southern California breast cancer therapy market share. There is a very steady decline from highest to lowest market shares.

Which facility types are treating the most breast cancer patients?


Fig. 5 Created using the Definitive Healthcare PatientFinder platform in March 2020.

Bellemare then goes even deeper into the patient journey, showing webinar attendees that the majority of breast cancer patients in the southern California area shuffle back and forth between short-term care hospitals and their primary physician’s office. There is a visible and steep drop-off when comparing these two leading location types to other patient options, like clinics and ambulatory surgery centers.

Who are key opinion-leaders in breast cancer treatment?

A main goal for any organization doing this type of market analysis should always be to identify relevant key opinion-leaders (KOLs) — industry experts that can help make the case for a new technology or therapy and, ultimately, ensure a timely, effective, and successful go-to-market. A KOL is someone who has speaking power within a market, as well as extensive firsthand experience with a major pain point that the introduced product can ease or fix.

In the webinar, Bellemare gave a very specific example of what a key opinion-leader should look like. In this instance, her name is Sibel Blau, MD and she is an oncology specialist. Treating primarily out of Northwest Medical Specialties in Bonney Lake, WA — she has seen a significant number of breast cancer patients over the course of her career.

At the time of this presentation, Dr. Blau had treated approximately 1,150 breast cancer patients. It’s experts like Dr. Blau that would likely care the most about revolutionizing treatment patterns with new therapies and technologies. These are the types of key opinion-leaders that should matter most when forming intelligent go-to-market strategies that work smarter, not harder — and deliver real results.

Learn more

Looking for more information on how you can replicate this market strategy for your own business needs? Good news — you can watch the webinar replay for a more in-depth discussion about not only breast cancer market trends, but also prostate cancer and lymphoma trends as well.


ABOUT THE AUTHOR

Tarell Morris

An English graduate and a tech nerd — I enjoy reading, writing, and getting involved with some technical nitty-gritty and design when time and opportunity allow for it. Some favorite books of mine ...


Continue Reading